PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The World Mitochondria Society will host Targeting Mitochondria 2023 with challenging visions in Berlin

The World Mitochondria Society will host Targeting Mitochondria 2023 with challenging visions in Berlin
2023-10-03
(Press-News.org) Targeting Mitochondria 2023

Location: Steigenberger Hotel Am Kanzleramt, Berlin 

Date: October 11-13

Network with over 210 participants and stay updated with the latest advancements and research on mitochondria. With more than 83 communications, this year's event promises to expand your understanding of mitochondria and its pivotal role in health and disease.

Mitochondria will pave the way for the next breakthroughs in medicine, stated Prof. Volkmar Weissig, president of the World Mitochondria Society (WMS), and Prof. Marvin Edeas Chairman of the scientific committee. We are impressed with the caliber of speakers and the groundbreaking topics presented. The recent discoveries in the realm of mitochondria, coupled with innovative approaches to treat various diseases linked to mitochondrial alterations, have been enlightening.

“We are undoubtedly at the era of deep transformation, shaping the medicine of tomorrow” Stated Volkmar Weissig and Marvin Edeas.

 

Highlighted WMS Speakers 2023

Vladimir Gogvadze, Karolinska Institutet, Sweden Alessandro Prigione, Heinrich Heine University (HHU) Düsseldorf, Germany Ian Holt, Instituto de Investigación Sanitaria Biodonostia, Spain Paul Hwang, National Heart, Lung and Blood Institute, USA Paolo Bernardi, University of Padova, Italy James McCully, Boston Children’s Hospital, USA María Luz Martínez-Chantar, CIC bioGUNE, Spain Carsten Culmsee, University of Marburg, Germany Egbert Mik, Erasmus MC, The Netherlands Peter Rehling, University Medical Center Göttingen, Germany Marta Murgia, University of Padova, Italy Nils Wiedemann, Universität Freiburg, Germany Jiri Neuzil, Griffith University, Australia Lawrence Grossman, Wayne State University, USA Mercedes Rincon, University of Colorado Anschutz School of Medicine, USA Patrick J. Rochette, Université Laval, Canada Afshin Beheshti, Blue Marble Space Institute of Science, USA Giuseppe Orlando, Wake Forest University, USA Yuma Yamada, Hokkaido University, Japan Marc-André Sirard, Université Laval, Canada Mark S. Kindy, University of South Florida, USA Sang-Bing Ong, The Chinese University of Hong Kong, China Arupratan Das, Indiana University School of Medicine, USA Ciro Leonardo Pierri, University of Bari Aldo Moro, Italy You can learn about all the communication that will be presented in the Targeting Mitochondria 2023 program.

 

Who is attending Targeting Mitochondria 2023?

Attendees from 30+ different countries will be gathered at the WMS 14th World Congress.

Among the attending industries:

Stealth Therapeutics, Mitotech, Anklam Extrakt GmbH, Cellvie Bio, CERES BRAIN Therapeutics, Danone Nutrica Research, Droia Labs - Metaptys NV, IXEAL, Kyowa Kirin Co., Ltd. , medDigital, Mitoq, mse Pharmazeutika GmbH, Nanolive, syntivia, Thermo Fisher Scientific, UCB Pharma SRL…

Among the academic attendees:

Åbo Akademi University, Aging and Inflammation Research Lab (INIBIC), Biomedical Sciences Research Centre, BiomedicalCenter Speyer, CHA university, Charles University, Children's Hospital of Philadelphia, China Agricultural University, Columbia University, Comenius University in Bratislava, Czech Academy of Sciences, De Montfort University, Deutsches Zentrum für Neurodegenerative Erkrankungen, Erasmus Medical center, Eurac research, Fondazione Ricerca Biomedica Avanzata Onlus, Foundation for Liver Research, Freie Universitat, General University Hospital, Hokkaido University, IMol Polish Academy of Sciences, Institute Pasteur, Instituto Nacional de Cardiología, IUF – Leibniz-Institut für umwelt- medizinische Forschung GmbH, Johns Hopkins Uinversity….

 

Supporters of the 14th WMS World Congress: 

Thanks to Stealth Biotherapeutics and Mitotech for supporting this year’s meeting.

Also, the Journal of Mitochondria, Plastids and Endosymbiosis will be publishing the abstracts of Targeting Mitochondria 2023.

For comprehensive details on speakers, topics, and event schedules, please visit the official Targeting Mitochondria 2023 website: www.wms-site.com.

Join us in Berlin and be at the forefront of mitochondrial research!

END

[Attachments] See images for this press release:
The World Mitochondria Society will host Targeting Mitochondria 2023 with challenging visions in Berlin

ELSE PRESS RELEASES FROM THIS DATE:

New strategy for eye condition could replace injections with eyedrops

2023-10-03
A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness. Wet age-related macular degeneration causes vision loss due to the uncontrolled growth and leakage of blood vessels in the back of the eye. A new paper in Cell Reports Medicine led by UIC researcher Yulia Komarova finds that a small-molecule inhibitor can reverse damage from AMD and promote regenerative and healing processes.  The drug can also be delivered via eyedrops — an improvement over current ...

Aston University engineering graduate launches first AI powered grill

Aston University engineering graduate launches first AI powered grill
2023-10-03
Graduate Suraj Sudera created an AI powered grill to cook the perfect steak. His love of engineering led him to create the device called Perfecta™ He founded Birmingham based start-up SEERGRILLS which applies AI and advanced technologies to improve cooking.   An Aston University engineering graduate has created the world’s first AI powered grill. Suraj Sudera has created a cooking device called Perfecta™ which cooks the perfect steak in 90 seconds. Suraj graduated from Aston University in 2015 with a BEng in Mechanical Engineering and ...

IU cancer researcher receives $2.2 million grant for metastatic breast cancer research

2023-10-03
INDIANAPOLIS— A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development—and how to stop it. Cells called macrophages usually perform essential tasks as part of the immune system, but breast cancer cells can hijack them to protect cancer cells and help them grow. When this happens, they become tumor-associated macrophages (TAMs). “Our goal is to interrupt that communication process between those two cell ...

Using recent diagnostic scans can substantially cut time to treatment for patients needing urgent palliation

2023-10-03
SAN DIEGO, October 3, 2023 — Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some people spend waiting for urgent treatment, improving the patient experience, a new study suggests. Patients who may benefit from this expedited process typically are experiencing pain or other debilitating symptoms, such as an airway blockage. Relying upon existing, recent scans instead of taking new ones reduced the time these patients spent at a cancer treatment center, from nearly five hours to under 30 minutes, ...

Brain regions identified that may play a role in Sudden Unexpected Death in Epilepsy

Brain regions identified that may play a role in Sudden Unexpected Death in Epilepsy
2023-10-03
New findings may take scientists a step closer to understanding what causes SUDEP—Sudden Unexpected Death in Epilepsy—a rare but fatal complication of epilepsy.  There are about 3,000 deaths from SUDEP each year in the U.S. The biggest risk factor is epilepsy that is not well controlled with medication or surgery, but the exact cause of SUDEP is not known. However, increasing evidence suggests that loss of breathing, or apnea, that persists after a seizure is a major cause of SUDEP.  In the new study, University of Iowa neuroscientists found that stimulating a specific ...

Researchers report protein mutation creates ‘super’ T cells with potential to fight off cancer and infections

2023-10-03
Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people’s own immune system T cells to fight cancer. The findings were published Oct. 3 in the journal JCI-Insight. “Maximizing the effectiveness of T-cell-based therapies remains a critical challenge,” says David Kass, M.D., Abraham and Virginia Weiss Professor of Cardiology at the Johns Hopkins University School of ...

Enhancing the efficiency of plant regeneration

Enhancing the efficiency of plant regeneration
2023-10-03
Crop modification can be traced to the beginning of agriculture and human civilization. Native Americans, for example, developed corn from a wild grass called teosinte more than 7,000 years ago. Methods to increase crop resiliency and sustainability have evolved, and improved, over time. Biotechnology, or the use of biology to develop new products and organisms, is an application that holds great promise for impactful changes to the agricultural systems. Through this method, the DNA in plant cells is modified — for instance ...

Registration now open for Energy Department’s National Science Bowl®

2023-10-03
Washington, D.C. – Registration is open for the 34th National Science Bowl® (NSB), hosted by the U.S. Department of Energy (DOE) Office of Science. Thousands of students compete in the contest annually as it has grown into one of the largest academic math and science competitions in the country. Teams – four or five students and a teacher who serves as a coach – can sign up to participate in the NSB by registering with the coordinator for their regional competition. Details can be found on the NSB registration page. The competition is divided into two categories: high school and middle school. Regional competitions typically last one or two days ...

Disaster-proofing sustainable neighborhoods requires thorough long-term planning, new Concordia study shows

Disaster-proofing sustainable neighborhoods requires thorough long-term planning, new Concordia study shows
2023-10-03
Individual neighbourhoods will be intimately involved in providing local solutions to collective problems. One measure will be distributed renewable energy production — energy produced at local levels, either by solar technology, wind or other methods, will push cities to achieve their net-zero targets. However, even these power-generating neighbourhoods will remain vulnerable to power outages resulting from natural disasters such as hurricanes, fires or floods. And all of these are likely to become increasingly common due to the effects of climate change. ...

Carbon-capture tree plantations threaten tropical biodiversity for little gain, ecologists say

Carbon-capture tree plantations threaten tropical biodiversity for little gain, ecologists say
2023-10-03
The increasingly urgent climate crisis has led to a boom in commercial tree plantations in an attempt to offset excess carbon emissions. However, authors of a peer-reviewed opinion paper publishing October 3 in the journal Trends in Ecology and Evolution argue that these carbon-offset plantations might come with costs for biodiversity and other ecosystem functions. Instead, the authors say we should prioritize conserving and restoring intact ecosystems. “Despite the broad range of ecosystem functions and services provided ...

LAST 30 PRESS RELEASES:

Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments

Enhance and revise for better low-light image enhancement

Multiple ways to evolve tiny knee bone could have helped humans walk upright

UBCO study explores access to psychedelics for therapeutic use

Lower diligence level linked to higher cardiovascular disease risk in type 2 diabetes

Statins cost effective and linked to better health outcomes in older people

Abdominal fat linked to widespread chronic pain, especially in women

Wearable brain imaging device shines a light on how babies respond in real-world situations

"Cuddle hormone" oxytocin may provide pain relief and help curb harmful opioid use

Study reveals mechanism that activates glucose production in the liver in response to stress

Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS compared to placebo

Weight loss of up to 13% achieved in three months with once-a-day tablet, phase 1 trial finds

Time-restricted eating improves blood sugar control in adults at risk of type 2 diabetes regardless of time of day

Individuals with complications of diabetes are at higher risk of gum disease, Danish study finds

Weight loss drug liraglutide is safe and effective in children under 12, study finds

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

The glug of it all

UTA to build netted drone facility in Fort Worth

Streamlining energy regulations on Native American reservations could help alleviate poverty

UT microbiologist Wilhelm honored as Fellow of the Royal Society of Canada

NCCN Policy Summit explores how to build an inclusive cancer center workplace culture that better serves everybody

Games, puzzles and reading can slow cognitive decline in the elderly — even in those with mild cognitive impairment

An antidiabetic helps the immune system recognize reservoirs of HIV

Department of Energy grant advances clean energy studies

Finding the right path(way) to reduce fat accumulation in the liver

MicroDicer and MicroGrater make quick work of tumor dissection

Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer

LUMINOSITY trial demonstrates telisotuzumab vedotin shows durable response in Asian patients with c-Met protein-overexpressing EGFR WT nonsquamous NSCLC

PM2.5 exposure may affect lung cancer in women who have never smoked

Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC presented at WCLC 2024

[Press-News.org] The World Mitochondria Society will host Targeting Mitochondria 2023 with challenging visions in Berlin